CareerPlanGet AI match score →
🌐 Remote💼 Full-time🗓 2026-06-25

Core

Building the first dedicated commercial presence for an AI-native, no-code manufacturing platform in Japan's pharmaceutical and life sciences industry.

Role type

Founding Account Executive (Life Sciences)

Builds

AI-native, no-code digital manufacturing platform

Domain

Manufacturing technology / Life Sciences / Pharma

Deliverable

client delivery

Required skills

Enterprise sales in life sciences, C-suite to front-line stakeholder management, long deal cycle navigation, multi-stakeholder buying committee management, validation/qualification process expertise, knowledge of GxP, 21 CFR Part 11, MES, ERP, eBR, eDHR, LIMS, LES

Preferred skills

Experience with proof of concept and validation projects

Technologies

Tulip platform, ERP, MES, GxP, eBR, eDHR, LIMS, LES, 21 CFR Part 11

Responsibilities

Presenting solutions to C-suite executives and front-line manufacturing operators, navigating complex enterprise sales cycles, managing opportunities from pipeline to closure including proof of concept and validation

Seniority

Founding, hands-on IC

Rewrite
## About Tulip Manufacturing accounts for nearly 20% of the global economy yet remains one of the least digitized industries on earth. Tulip was founded at MIT to change that — an AI-native, no-code platform built for the people on the manufacturing front line. In January 2026 we reached a $1.3B valuation and continue to grow double digits year over year. We have been recognized as a World Economic Forum Global Innovator and a Gartner leader. ## About the opportunity in Japan Japan is the world's fourth-largest pharmaceutical market, home to some of the most demanding manufacturing standards anywhere — and one of Tulip's most strategic markets. Mitsubishi Electric has made a strategic investment in Tulip, and DMG MORI has been a longstanding partner. These relationships reflect how seriously we are committed to this market. Global pharma leaders including AstraZeneca, Eli Lilly, J&J, and Chugai are already running on Tulip to digitize operations — from electronic batch records and eDHR to line clearance and deviation management. The market is real. The customers are real. The foundation is there. What we need now is the person who will build on it. This is a founding role: the first dedicated commercial presence for Tulip in Japan's pharmaceutical and life sciences industry. We're looking for someone who is ready to own it. This role is located in Japan - We are a remote work environment for 2026 with future plans to open up an office in 2027. Candidates must possess a valid Japanese work visa at the time of application. We are unable to provide visa sponsorship for this position. ## About You - You are on the front lines working with large strategic pharmaceutical, biotech, and life sciences accounts in Japan, presenting from C-suite executives to front-line manufacturing operators and QA leaders. - You have successfully navigated complex enterprise sales into life sciences companies, with deep understanding of the long deal cycles, multi-stakeholder buying committees, and validation/qualification processes that define this industry. - Acronyms like ERP, MES, GxP, eBR, eDHR, LIMS, LES, and 21 CFR Part 11 are part of your daily conversations. - You are used to building, managing, and closing opportunities within a new pipeline — including proof of concept, validation
Sourced via wellfound · Listed on CareerPlan, which tracks 70,000+ jobs from 20+ sources.
Apply on Wellfound ↗